Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy.

作者信息

Godfrey James, Querfeld Christiane, Song Joo

机构信息

City of Hope Comprehensive Cancer Center, Duarte, CA

出版信息

N Engl J Med. 2024 Sep 5;391(9):869-870. doi: 10.1056/NEJMc2408733.

DOI:10.1056/NEJMc2408733

PMID:39231354

Abstract

摘要

相似文献

[1]

Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy.

N Engl J Med. 2024-9-5

[2]

Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy. Reply.

N Engl J Med. 2024-9-5

[3]

Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy.

N Engl J Med. 2024-6-13

[4]

T-Cell Neoplasms after B-Cell Neoplasms - The Pre-CAR T-Cell Era.

N Engl J Med. 2024-8-15

[5]

Indolent CD4+ CAR T-Cell Lymphoma after Cilta-cel CAR T-Cell Therapy.

N Engl J Med. 2024-6-13

[6]

Cytokine Release Syndrome and Neurotoxicity Following CD19 CAR-T in B-Cell Lymphoma.

Transplant Cell Ther. 2025-4-25

[7]

Chimeric Antigen Receptor-Engineered T Cell Therapy in Lymphoma.

Curr Oncol Rep. 2019-3-27

[8]

Safety and tolerability of conditioning chemotherapy followed by CD19-targeted CAR T cells for relapsed/refractory CLL.

JCI Insight. 2019-4-2

[9]

Tumor Microenvironment Composition and Severe Cytokine Release Syndrome (CRS) Influence Toxicity in Patients with Large B-Cell Lymphoma Treated with Axicabtagene Ciloleucel.

Clin Cancer Res. 2020-9-15

[10]

The Fate(s) of CAR T-Cell Therapy: Navigating the Risks of CAR+ T-Cell Malignancy.

Blood Cancer Discov. 2024-7-1

引用本文的文献

[1]

Current landscape of vector safety and genotoxicity after hematopoietic stem or immune cell gene therapy.

Leukemia. 2025-4-8

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

新学期，新优惠

Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

推荐工具

Suppr 超能文献

相似文献

引用本文的文献